Skip to main content
PAHC logo

PAHC · Phibro Animal Health Corp · Webcasts, Transcripts & Audio

Track PAHC — free
$36.61 -0.58 (-1.56%)
Market Cap
$1.40B
Shares
40.60M
Volume · Oct 6 133.25K Avg daily vol (3M) 238.9K

Phibro Animal Health Corp Webcasts

Earnings calls, investor updates, investor days and conferences for Phibro Animal Health Corp (PAHC), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Earnings call
FY26 · Q4
2026-08-27
Phibro Animal Health Corp (PAHC) Q4 2026 Earnings Call
Revenue
$396.75M*
▲ 4.8% YoY
Gross margin
33.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Conference
Investor event
2026-05-27
Phibro Animal Health Corp (PAHC) May 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q3
2026-05-07
Phibro Animal Health Corp (PAHC) Q3 2026 Earnings Call Transcript
Confident tone Updated fiscal 2026 guidance Brazil antimicrobial regulatory change Animal health segment performance
Revenue
$383.54M
▲ 10.3% YoY
Diluted EPS
$0.59
▲ 15.7% YoY
Gross margin
32.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2026-02-05
Phibro Animal Health Corp (PAHC) Q2 2026 Earnings Call
Confident tone Animal health segment growth and MFA integration Phibro Forward cost and margin initiatives Raised full-year guidance
Revenue
$373.91M
▲ 20.9% YoY
Diluted EPS
$0.67
▲ 737.5% YoY
Gross margin
35.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2025-11-06
Phibro Animal Health Corp (PAHC) Q1 2026 Earnings Call Transcript
Confident tone Animal Health Segment Growth Full-Year Guidance Raise Legacy Business & Quarterly Mix
Revenue
$363.89M
▲ 39.7% YoY
Diluted EPS
$0.65
▲ 282.4% YoY
Gross margin
32.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2025-08-28
Phibro Animal Health Corp (PAHC) Q4 2025 Earnings Call Transcript
Confident tone FY2026 Guidance Zoetis MFA Acquisition / Integration Animal Health Segment Growth
Revenue
$378.70M*
▲ 38.6% YoY
Gross margin
29.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-05-08
Phibro Animal Health Corp (PAHC) Q3 2025 Earnings Call Transcript
Confident tone Guidance update and outlook Tariffs and supply chain mitigation Lobbying for animal health tariff exceptions and FX
Revenue
$347.82M
▲ 32.1% YoY
Diluted EPS
$0.51
▲ 142.9% YoY
Gross margin
30.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-02-05
Phibro Animal Health Corp (PAHC) Q2 2025 Earnings Call Transcript
Confident tone Animal Health Segment Growth Zoetis MFA Integration Phibro Forward Initiative
Revenue
$309.26M
▲ 23.7% YoY
Diluted EPS
$0.08
▲ 166.7% YoY
Gross margin
32.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2024-11-07
Phibro Animal Health Corp (PAHC) Q1 2025 Earnings Call Transcript
Confident tone Zoetis Medicated Feed Additive acquisition Strong organic growth and operating leverage Acquisition transition and financial dilution
Revenue
$260.43M
▲ 12.6% YoY
Diluted EPS
$0.17
Gross margin
32.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-08-29
Phibro Animal Health Corp (PAHC) Q4 2024 Earnings Call Transcript
Confident tone Fiscal 2025 guidance Animal Health segment growth Mineral Nutrition and Performance Products
Revenue
$273.16M*
▲ 7.1% YoY
Gross margin
31.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-05-09
Phibro Animal Health Corp (PAHC) Q3 2024 Earnings Call Transcript
Confident tone Animal Health Segment Growth FY2024 Financial Guidance Zoetis MFA Acquisition
Revenue
$263.22M
▲ 7.1% YoY
Diluted EPS
$0.21
▼ 16% YoY
Gross margin
30.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-02-07
Phibro Animal Health Corp (PAHC) Q2 2024 Earnings Call Transcript
Positive tone Vaccine growth Guidance and outlook Mineral Nutrition and Performance Products headwinds
Revenue
$249.94M
▲ 2.2% YoY
Diluted EPS
$0.03
▼ 83.3% YoY
Gross margin
31.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2023-11-09
Phibro Animal Health Corp (PAHC) Q1 2024 Earnings Call Transcript
Revenue
$231.35M
▼ 0.5% YoY
Diluted EPS
$-0.20
▼ 300% YoY
Gross margin
29.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-08-31
Phibro Animal Health Corp (PAHC) Q4 2023 Earnings Call Transcript
Revenue
$255.05M*
▼ 0.1% YoY
Gross margin
30.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-05-04
Phibro Animal Health Corp (PAHC) Q3 2023 Earnings Call Transcript
Revenue
$245.67M
▲ 2.5% YoY
Diluted EPS
$0.25
▼ 43.2% YoY
Gross margin
30.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-02-08
Phibro Animal Health Corp (PAHC) Q2 2023 Earnings Call Transcript
Revenue
$244.65M
▲ 5.1% YoY
Diluted EPS
$0.18
▼ 58.1% YoY
Gross margin
31.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2022-11-10
Phibro Animal Health Corp (PAHC) Q1 2023 Earnings Call Transcript
Revenue
$232.52M
▲ 8.3% YoY
Diluted EPS
$0.10
▼ 37.5% YoY
Gross margin
29.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-08-25
Phibro Animal Health Corp (PAHC) Q4 2022 Earnings Call Transcript
Revenue
$255.26M*
▲ 15.9% YoY
Gross margin
30.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-05-05
Phibro Animal Health Corp (PAHC) Q3 2022 Earnings Call Transcript
Revenue
$239.62M
▲ 13.2% YoY
Diluted EPS
$0.44
▲ 46.7% YoY
Gross margin
29.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-02-09
Phibro Animal Health Corp (PAHC) Q2 2022 Earnings Call Transcript
Revenue
$232.71M
▲ 12.9% YoY
Diluted EPS
$0.43
▲ 34.4% YoY
Gross margin
30.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2021-11-03
Phibro Animal Health Corp (PAHC) Q1 2022 Earnings Call Transcript
Revenue
$214.66M
▲ 10% YoY
Diluted EPS
$0.16
▼ 46.7% YoY
Gross margin
30.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-08-26
Phibro Animal Health Corp (PAHC) Q4 2021 Earnings Call Transcript
Revenue
$220.28M*
▲ 18.5% YoY
Gross margin
31.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-05-07
Phibro Animal Health Corp (PAHC) Q3 2021 Earnings Call Transcript
Revenue
$211.73M
▲ 0.5% YoY
Diluted EPS
$0.30
▼ 9.1% YoY
Gross margin
32.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-02-03
Phibro Animal Health Corp (PAHC) Q2 2021 Earnings Call Transcript
Revenue
$206.15M
▼ 3.7% YoY
Diluted EPS
$0.32
▲ 10.3% YoY
Gross margin
33.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2020-11-05
Phibro Animal Health Corp (PAHC) Q1 2021 Earnings Call Transcript
Revenue
$195.19M
▲ 2.9% YoY
Diluted EPS
$0.30
▲ 400% YoY
Gross margin
32.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-08-27
Phibro Animal Health Corp (PAHC) Q4 2020 Earnings Call Transcript
Revenue
$185.88M*
▼ 8.8% YoY
Gross margin
32.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-05-08
Phibro Animal Health Corp (PAHC) Q3 2020 Earnings Call Transcript
Revenue
$210.74M
▲ 2.4% YoY
Diluted EPS
$0.33
▼ 10.8% YoY
Gross margin
33.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-02-03
Phibro Animal Health Corp (PAHC) Q2 2020 Earnings Call Transcript
Revenue
$214.01M
▼ 1.9% YoY
Diluted EPS
$0.29
▼ 19.4% YoY
Gross margin
32.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–28 of 28 webcasts
Key facts CIK 1069899 CUSIP 71742Q106 13F (30d) 4 filings 4 filers Visit website Investor relations